Перейти к содержанию

Astrana Health, Inc. (ASTH) stock: revenue, earnings & dividend

Astrana Health, Inc. (ASTH, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener ASTH · Nasdaq Dienstleistungen US-CA

Key figures

Fiscal year
2025
Revenue
3.18 bn $
Revenue growth
56.4 %
Revenue growth 5y (p.a.)
35.9 %
Net income
24 m $
Net margin
0.8 %
Operating margin
2.5 %
Earnings per share (diluted)
0.46 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
2.22 bn $
Equity
779 m $
Equity ratio
35.1 %
Return on equity
3.1 %
Cash
429 m $
Operating cash flow
115 m $
Free cash flow
104 m $
Shares outstanding
55,800,063

History

Revenue by fiscal year

2016 306 m $
2017 358 m $
2018 520 m $
2019 561 m $
2020 687 m $
2021 774 m $
2022 1.14 bn $
2023 1.39 bn $
2024 2.03 bn $
2025 3.18 bn $

Net income by fiscal year

2016 11.5 m $
2017 25.8 m $
2018 10.8 m $
2019 14.1 m $
2020 37.7 m $
2021 46 m $
2022 46 m $
2023 58 m $
2024 50 m $
2025 24 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20253.18 bn $24 m $0.46 $–115 m $
20242.03 bn $50 m $0.90 $–52.2 m $
20231.39 bn $58 m $1.29 $–68.2 m $
20221.14 bn $46 m $0.99 $–82.1 m $
2021774 m $46 m $1.52 $–70.3 m $
2020687 m $37.7 m $1.01 $–46.2 m $
2019561 m $14.1 m $0.39 $–13.7 m $
2018520 m $10.8 m $0.29 $–25.5 m $
2017358 m $25.8 m $0.90 $–51.8 m $
2016306 m $11.5 m $0.41 $–21.9 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)